Skip to content
Wenlo
Sign in
← Markets
Market open · Closes 4:00 PM ET

ILMN Illumina Inc.

NASDAQ
$230.25−$5.74 (−2.43%)

As of 10:37:00 AM ET · 18 min old

Loading chart…

Open
$238.50
Previous close
$235.99
Day range
227.74 – 238.50
52-week range
112.65 – 309.35
Volume
26.7K
Avg volume (3M)
2.8M
Market cap
$35.6B
P/E (TTM)
40.62
EPS (TTM)
$5.81
Beta
1.42
Dividend yield
0.00%
Next earnings
—
Ex-dividend
—
Sector
Healthcare

About Illumina Inc.

Illumina Inc. is a global genomics and life sciences company that develops DNA sequencing and array-based technologies used to analyze genetic variation and biological function. Its products and systems support research, clinical testing, and applied markets across areas such as oncology, inherited and infectious diseases, reproductive health, and molecular diagnostics. Illumina also provides sequencing consumables, instruments, software, and support services that help laboratories generate, interpret, and manage genomic data. The company serves customers including academic institutions, genomic research centers, hospitals, pharmaceutical and biotechnology companies, and clinical laboratories. Headquartered in San Diego, California, and founded in 1998, Illumina plays a central role in making genomic analysis more widely accessible for research and healthcare applications.

ILMN news and filings

Loading filings…

Filings from SEC EDGAR.